According to previous studies, miR-432-5p could target and regulate E2F3, playing an important role in breast cancer [22], nasopharyngeal cancer [23], osteosarcoma [24], melanoma [25], and gastric cancer [26]. This evidence concerns the gene E2F3 and nasopharyngeal carcinoma.